Home › Down Syndrome › Arizona › Phoenix
Down Syndrome clinical trials in Phoenix, AZ
6 studies for Down Syndrome are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Phoenix Childrens Hospital, Phoenix
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- Phoenix Childrens Hospital, Phoenix
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
RecruitingObservational study
- Valley Perinatal Services, Phoenix
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RecruitingObservational study
- Barrow Neurological Institute, Phoenix
Patterns of Neurodevelopmental Disorders
RecruitingObservational study
- Rossignol Medical Center, Phoenix
Pediatric Down Syndrome Post-Approval Study
Recruiting
- Phoenix Children's Hospital, Phoenix
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Durham, NC6 studies
- Houston, TX6 studies
- Ann Arbor, MI5 studies
- Cincinnati, OH5 studies
- Philadelphia, PA5 studies
- Cleveland, OH5 studies
- Kansas City, KS5 studies
- Orlando, FL5 studies
- Nashville, TN5 studies
- Seattle, WA4 studies
- Atlanta, GA4 studies
Other studies in Phoenix
- Colorectal Cancer25 studies
- Breast Cancer25 studies
- Obesity23 studies
- Metastatic Cancer20 studies
- Non-Small Cell Lung Cancer20 studies
- Heart Failure18 studies
- Pancreatic Cancer17 studies
- Cancer (all types)17 studies
- Prostate Cancer17 studies
- Multiple Myeloma16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.